John J Brewington1, Erin T Filbrandt2, F J LaRosa2, Alicia J Ostmann2, Lauren M Strecker2, Rhonda D Szczesniak3, John P Clancy2. 1. Division of Pulmonary Medicine, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, 3333 Burnet Avenue/MLC 2021, Cincinnati, OH, USA. Electronic address: john.brewington@cchmc.org. 2. Division of Pulmonary Medicine, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, 3333 Burnet Avenue/MLC 2021, Cincinnati, OH, USA. 3. Division of Biostatistics and Epidemiology, Cincinnati Children's Hospital Medical Center, 3333 Burnet Avenue/MLC 2021, Cincinnati, OH, USA.
Abstract
BACKGROUND: Expansion of CFTR modulators to patients with rare/undescribed mutations will be facilitated by patient-derived models quantifying CFTR function and restoration. We aimed to generate a personalized model system of CFTR function and modulation using non-surgically obtained nasal epithelial cells (NECs). METHODS: NECs obtained by curettage from healthy volunteers and CF patients were expanded and grown in 3-dimensional culture as spheroids, characterized, and stimulated with cAMP-inducing agents to activate CFTR. Spheroid swelling was quantified as a proxy for CFTR function. RESULTS: NEC spheroids recapitulated characteristics of pseudostratified respiratory epithelia. When stimulated with forskolin/IBMX, spheroids swelled in the presence of functional CFTR, and shrank in its absence. Spheroid swelling quantified mutant CFTR restoration in F508del homozygous cells using clinically available CFTR modulators. CONCLUSIONS: NEC spheroids hold promise for understanding rare CFTR mutations and personalized modulator testing to drive evaluation for CF patients with common, rare or undescribed mutations. Portions of this data have previously been presented in abstract form at the 2016 meetings of the American Thoracic Society and the 2016 North American Cystic Fibrosis Conference.
BACKGROUND: Expansion of CFTR modulators to patients with rare/undescribed mutations will be facilitated by patient-derived models quantifying CFTR function and restoration. We aimed to generate a personalized model system of CFTR function and modulation using non-surgically obtained nasal epithelial cells (NECs). METHODS: NECs obtained by curettage from healthy volunteers and CFpatients were expanded and grown in 3-dimensional culture as spheroids, characterized, and stimulated with cAMP-inducing agents to activate CFTR. Spheroid swelling was quantified as a proxy for CFTR function. RESULTS: NEC spheroids recapitulated characteristics of pseudostratified respiratory epithelia. When stimulated with forskolin/IBMX, spheroids swelled in the presence of functional CFTR, and shrank in its absence. Spheroid swelling quantified mutant CFTR restoration in F508del homozygous cells using clinically available CFTR modulators. CONCLUSIONS: NEC spheroids hold promise for understanding rare CFTR mutations and personalized modulator testing to drive evaluation for CFpatients with common, rare or undescribed mutations. Portions of this data have previously been presented in abstract form at the 2016 meetings of the American Thoracic Society and the 2016 North American Cystic Fibrosis Conference.
Authors: Claire E Wainwright; J Stuart Elborn; Bonnie W Ramsey; Gautham Marigowda; Xiaohong Huang; Marco Cipolli; Carla Colombo; Jane C Davies; Kris De Boeck; Patrick A Flume; Michael W Konstan; Susanna A McColley; Karen McCoy; Edward F McKone; Anne Munck; Felix Ratjen; Steven M Rowe; David Waltz; Michael P Boyle Journal: N Engl J Med Date: 2015-05-17 Impact factor: 91.245
Authors: R Dekkers; L A W Vijftigschild; A M Vonk; E Kruisselbrink; K M de Winter-de Groot; H M Janssens; C K van der Ent; J M Beekman Journal: J Cyst Fibros Date: 2014-11-06 Impact factor: 5.482
Authors: Puay-Wah Phuan; Guido Veit; Joseph A Tan; Walter E Finkbeiner; Gergely L Lukacs; A S Verkman Journal: Mol Pharmacol Date: 2015-08-05 Impact factor: 4.436
Authors: Michael P Boyle; Scott C Bell; Michael W Konstan; Susanna A McColley; Steven M Rowe; Ernst Rietschel; Xiaohong Huang; David Waltz; Naimish R Patel; David Rodman Journal: Lancet Respir Med Date: 2014-06-24 Impact factor: 30.700
Authors: John P Clancy; Rhonda D Szczesniak; Melissa A Ashlock; Sarah E Ernst; Lijuan Fan; Douglas B Hornick; Philip H Karp; Umer Khan; James Lymp; Alicia J Ostmann; Amir Rezayat; Timothy D Starner; Shajan P Sugandha; Hongtao Sun; Nancy Quinney; Scott H Donaldson; Steven M Rowe; Sherif E Gabriel Journal: PLoS One Date: 2013-09-10 Impact factor: 3.240
Authors: John J Brewington; Erin T Filbrandt; Francis J LaRosa; Jessica D Moncivaiz; Alicia J Ostmann; Lauren M Strecker; John P Clancy Journal: J Vis Exp Date: 2018-04-11 Impact factor: 1.355
Authors: Carolin A Boecking; Peter Walentek; Lorna T Zlock; Dingyuan I Sun; Paul J Wolters; Hiroaki Ishikawa; Byung-Ju Jin; Peter M Haggie; Wallace F Marshall; Alan S Verkman; Walter E Finkbeiner Journal: Am J Physiol Lung Cell Mol Physiol Date: 2022-01-26 Impact factor: 5.464
Authors: John Paul Clancy; Calvin U Cotton; Scott H Donaldson; George M Solomon; Donald R VanDevanter; Michael P Boyle; Martina Gentzsch; Jerry A Nick; Beate Illek; John C Wallenburg; Eric J Sorscher; Margarida D Amaral; Jeffrey M Beekman; Anjaparavanda P Naren; Robert J Bridges; Philip J Thomas; Garry Cutting; Steven Rowe; Anthony G Durmowicz; Martin Mense; Kris D Boeck; William Skach; Christopher Penland; Elizabeth Joseloff; Hermann Bihler; John Mahoney; Drucy Borowitz; Katherine L Tuggle Journal: J Cyst Fibros Date: 2018-06-20 Impact factor: 5.482
Authors: John J Brewington; Erin T Filbrandt; F J LaRosa; Jessica D Moncivaiz; Alicia J Ostmann; Lauren M Strecker; John P Clancy Journal: JCI Insight Date: 2018-07-12
Authors: Matthew S McCravy; Nancy L Quinney; Deborah M Cholon; Susan E Boyles; Timothy J Jensen; Andrei A Aleksandrov; Scott H Donaldson; Peadar G Noone; Martina Gentzsch Journal: Eur Respir J Date: 2020-07-30 Impact factor: 16.671